Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
ACS Medicinal Chemistry Letters
|
February 19, 2025
Erratum: Addition to "The Death of the Strategy of Classical Chiral Switches Is an Exaggeration"
Israel Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters
|
September 18, 2024
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and Future
Israel Agranat, Ilaria D'Acquarica
ACS Pharmacology & Translational Science
|
September 19, 2024
Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"
Ilaria D'Acquarica, Israel Agranat
ACS Pharmacology & Translational Science
|
February 17, 2023
The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy
Ilaria D'Acquarica, Israel Agranat
ACS Medicinal Chemistry Letters
|
January 14, 2026
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
Israel Agranat, Hava Ercegovic
The Journal of Organic Chemistry
|
March 29, 2003
Clar goblet and related non-Kekulé benzenoid LPAHs. A theoretical study
Sergey Pogodin, Israel Agranat
Topics in Current Chemistry
|
July 10, 2014
Stereochemistry of bistricyclic aromatic enes and related polycyclic systems
P Ulrich Biedermann, Israel Agranat
Journal of Medicinal Chemistry
|
September 5, 2014
"New drug" designations for new therapeutic entities: new active substance, new chemical entity, new biological entity, new molecular entity
Sarah K Branch, Israel Agranat
Drug Discovery Today
|
February 2, 2010
The strategy of enantiomer patents of drugs
Israel Agranat, Silvya R Wainschtein
ACS Medicinal Chemistry Letters
|
July 16, 2025
The Importance of Correct New Drug Designations: New "Novel Drug Entity" Designations
Sarah K Branch, Israel Agranat
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
ACS Medicinal Chemistry Letters
|
February 19, 2025
Erratum: Addition to "The Death of the Strategy of Classical Chiral Switches Is an Exaggeration"
Israel Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters
|
September 18, 2024
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and Future
Israel Agranat, Ilaria D'Acquarica
ACS Pharmacology & Translational Science
|
September 19, 2024
Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"
Ilaria D'Acquarica, Israel Agranat
ACS Pharmacology & Translational Science
|
February 17, 2023
The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy
Ilaria D'Acquarica, Israel Agranat
ACS Medicinal Chemistry Letters
|
January 14, 2026
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
Israel Agranat, Hava Ercegovic
The Journal of Organic Chemistry
|
March 29, 2003
Clar goblet and related non-Kekulé benzenoid LPAHs. A theoretical study
Sergey Pogodin, Israel Agranat
Topics in Current Chemistry
|
July 10, 2014
Stereochemistry of bistricyclic aromatic enes and related polycyclic systems
P Ulrich Biedermann, Israel Agranat
Journal of Medicinal Chemistry
|
September 5, 2014
"New drug" designations for new therapeutic entities: new active substance, new chemical entity, new biological entity, new molecular entity
Sarah K Branch, Israel Agranat
Drug Discovery Today
|
February 2, 2010
The strategy of enantiomer patents of drugs
Israel Agranat, Silvya R Wainschtein
ACS Medicinal Chemistry Letters
|
July 16, 2025
The Importance of Correct New Drug Designations: New "Novel Drug Entity" Designations
Sarah K Branch, Israel Agranat
Page
of 4